Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fassbender, K.
Right arrow Articles by Rossol, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fassbender, K.
Right arrow Articles by Rossol, S.
Neurology 1999;53:1104
© 1999 American Academy of Neurology


Articles

Interferon-{gamma}–inducing factor (IL-18) and interferon-{gamma} in inflammatory CNS diseases

K. Fassbender, MD, O. Mielke, MD, T. Bertsch, MD, F. Muehlhauser, M. Hennerici, MD, M. Kurimoto and S. Rossol, MD

From the Departments of Neurology (Drs. Fassbender, Mielke, Hennerici, and Muehlhauser), Internal Medicine (Dr. Rossol), and Institute of Clinical Chemistry (Dr. Bertsch), University of Heidelberg, Klinikum Mannheim, Germany; and Fujisaki Institute (Dr. Kurimoto), Hayashibara Laboratories Inc., Okayama, Japan.

Address correspondence and reprint requests to Dr. K. Fassbender, Department of Neurology, Klinikum Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer, D-68135 Mannheim, Germany.

OBJECTIVE: To examine the intrathecal production of a newly identified cytokine, interferon-{gamma}–inducing factor (IL-18), together with interferon-{gamma} itself, in inflammatory diseases of the CNS (i.e., bacterial meningitis, viral meningoencephalitis, and MS).

RESULTS: IL-18 concentrations in CSF were significantly increased in bacterial meningitis and tended toward increased levels in viral meningoencephalitis. In contrast, IL-18 was detectable only in a few patients with MS and healthy controls. Interestingly, interferon-{gamma} was significantly increased selectively in CSF of patients with viral meningoencephalitis.

CONCLUSION: The observation of an intrathecal release of IL-18 in patients with meningitis argues for a pathophysiologic role of this novel cytokine in immunity against invading microorganisms the CNS.

Key words: Interleukin-18—Bacterial meningitis—MS.




This article has been cited by other articles:


Home page
J AndrolHome page
M. Fraczek, D. Sanocka, M. Kamieniczna, and M. Kurpisz
Proinflammatory Cytokines as an Intermediate Factor Enhancing Lipid Sperm Membrane Peroxidation in In Vitro Conditions
J Androl, January 1, 2008; 29(1): 85 - 92.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
R. A. Kumar, C. Cann, J. E. Hall, P. S. Sudheer, and A. R. Wilkes
Predictive value of IL-18 and SC5b-9 for neurocognitive dysfunction after cardiopulmonary bypass
Br. J. Anaesth., March 1, 2007; 98(3): 317 - 322.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
M. Fraczek and M. Kurpisz
Inflammatory mediators exert toxic effects of oxidative stress on human spermatozoa
J Androl, March 1, 2007; 28(2): 325 - 333.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
J. E. Harris, M. Fernandez-Vilaseca, P. T. G. Elkington, D. E. Horncastle, M. B. Graeber, and J. S. Friedland
IFN{gamma} synergizes with IL-1{beta} to up-regulate MMP-9 secretion in a cellular model of central nervous system tuberculosis
FASEB J, February 1, 2007; 21(2): 356 - 365.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Chen, P. Iribarren, J. Huang, L. Zhang, W. Gong, E. H. Cho, S. Lockett, N. M. Dunlop, and J. M. Wang
Induction of the Formyl Peptide Receptor 2 in Microglia by IFN-{gamma} and Synergy with CD40 Ligand
J. Immunol., February 1, 2007; 178(3): 1759 - 1766.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. J. G. Zwijnenburg, T. van der Poll, S. Florquin, J. J. Roord, and A. M. van Furth
IL-1 Receptor Type 1 Gene-Deficient Mice Demonstrate an Impaired Host Defense Against Pneumococcal Meningitis
J. Immunol., May 1, 2003; 170(9): 4724 - 4730.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. Ariel, D. Novick, M. Rubinstein, C. A. Dinarello, O. Lider, and R. Hershkoviz
IL-12 and IL-18 induce MAP kinase-dependent adhesion of T cells to extracellular matrix components
J. Leukoc. Biol., July 1, 2002; 72(1): 192 - 198.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
F. Nicoletti, R. Di Marco, K. Mangano, F. Patti, E. Reggio, A. Nicoletti, K. Bendtzen, and A. Reggio
Increased serum levels of interleukin-18 in patients with multiple sclerosis
Neurology, July 24, 2001; 57(2): 342 - 344.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
G. YAMADA, N. SHIJUBO, K. SHIGEHARA, H. OKAMURA, M. KURIMOTO, and S. ABE
Increased Levels of Circulating Interleukin-18 in Patients with Advanced Tuberculosis
Am. J. Respir. Crit. Care Med., June 1, 2000; 161(6): 1786 - 1789.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by AAN Enterprises, Inc.